The Connect accelerator program has set Nov. 29 — that’s the Thursday after Thanksgiving — as the date for naming its latest set of Most Innovative New Products.
This year’s judges will choose among 23 finalists from San Diego County companies. To be eligible for an award, the product must have been first introduced after Jan. 1, 2016, never been selected as a contest finalist, and generated revenue from sales. That last rule doesn’t apply to companies submitting in one category: clinical-stage life science products.
This year’s finalists, in seven categories, are listed below.
Aerospace, Robotics and Transportation:
• Boxton, for Boxton logistics management software,
• Citadel Defense Co., for Citadel Titan counter-drone technology,
• General Atomics Aeronautical Systems Inc., for the MQ-9B SkyGuardian remotely piloted aircraft, and
• Robolink, for Linky software, which lets students test autonomous driving.
Cleantech, Sustainability and Energy:
• Primo Wind, for a freestanding, solar- and wind-driven security device called EnergiPlant, and
• soFC2 Inc., for soFC2, a device that converts excess carbon dioxide into natural gas.
Defense and Cybersecurity:
• Cubic Corp., for its M3X product family of computer networking modules,
• Formalloy, for the L-series 3-D metal printer,
• Gryphon Online Safety Inc., for the Gryphon secure mesh Wi-Fi system for the connected home, and
• Seacoast Science Inc., for its SC-V10 handheld bulk particle collector.
Information Communication Technologies and Software:
• Cubic Corp., for the Cubic Gateless Gateline for mass-transit applications,
• Qubitekk, for its Quantum Transceiver cybersecurity product, and
• Rosey, for Rosey — an online platform that reads students’ handwritten assessments and uses artificial intelligence to grade answers.
Life Science Diagnostics:
• Banyan Biomarkers, for Banyan BTI, a blood test to detect concussion,
• CureMatch, for PreciGene — which evaluates 4.5 million treatment options for cancer patients, and
• ThinkingNode Inc., for its Thinking Node artificial intelligence technology to evaluate complex biological systems.
Life Science Products (Clinical Stage) and Pharmaceuticals:
• Biological Dynamics, for its OmniVerita platform that analyzes cancer biomarkers,
• Greenwich Biosciences, for its Epidiolex cannabinoid medicine for treating seizures, and
• Neurocrine Biosciences, for Ingrezza (valbenazine) for treatment of tardive dyskinesia.
Life Science Research Tools and Medical Devices:
• Digital Proteomics, for Alicanto, a platform to discover novel antibody therapeutics from survivors of serious illnesses,
• QT Medical, for its QT ECG electrocardiogram products and services,
• StemoniX, for the microBrain 3-D Assay Ready Plate containing neural cells, and
• Tear Film Innovations Inc., for its iLux Dry Eye Treatment System.